Active surveillance
PROSTATE CANCER
On this page:
Overview
As surprising as it may seem, in some cases, if your cancer is confined within the prostate, your doctor may recommend waiting before you start treatment. He could opt for watchful waiting or active surveillance. There is a difference between the two approaches. Although we will address both approaches, the majority of the information on this page is about active surveillance, a treatment option for localized low-risk prostate cancer.
What is active surveillance?
Active surveillance is a way to monitor a slow-growing prostate cancer instead of treating it right away. The goal is to avoid unnecessary treatments or delay treatment and its possible side effects.
How do you explain this?
Prostate cancer is often slow-growing and can be present for many years and never spread, produce symptoms, or threaten the life of a patient. Active surveillance can be a treatment option if you are diagnosed with a prostate cancer that has a very low risk of progressing.
What is active surveillance?
Active surveillance means the healthcare team watches you closely. Treatment is given if your tumour shows signs of growing or if your cancer shows signs of an increased risk of progression. The term active surveillance gives you the impression that nothing is happening which is not necessarily the case. This is an active method based on closely monitoring your cancer’s progression.
Who can undergo active surveillance?
Active surveillance may be recommended if your cancer is still in its early stages and if it is at a low grade where it grows slowly. In this way, risks of erectile dysfunction and incontinence associated with this treatment can at least be temporarily avoided.
Choice-justifications
Choosing observation depends on a number of factors such as your general health, your age, and your family history. If your doctor feels that your death will be caused by a condition other than prostate cancer, he may recommend observation as your preferred choice of treatment.
This option is also dependent on how aggressive your cancer is. Well-differentiated, low-risk cancers are generally less aggressive and develop more slowly. Thus, you may be offered active surveillance if:
- the cancer is low grade with a Gleason score of 6
- the prostate-specific antigen (PSA) level is less than 10 ng/mL
- the cancer isn’t causing any symptoms
- you prefer not to have treatment right away so you can avoid treatment-related side effects and keep the quality of life that you’re used to
Advantages and limitations
Advantages of active surveillance
- No treatment side effects
- No change to your quality of life
Limitations of active surveillance
- Frequent follow-up visits and tests
- Induces stress and anxiety in many patients
- Natural history of each patient’s cancer can differ
Risks and complications
Although 100% reliable tools are not available to predict disease progression, the risk of progression to a more advanced stage of cancer or the loss of a treatment window is extremely rare because of your close medical follow-ups. Your doctor will start treating you as soon as symptoms or signs appear that your illness is changing. The cure rate remains the same and treatment after active surveillance is no more complicated or does not cause more side effects.
What to expect
Regular tests
Regular tests will be done about every 3–6 months to monitor your prostate cancer. This can vary depending on your situation.
- Prostate-specific antigen (PSA) test
- Physical examination, including a digital rectal exam (DRE)
- Prostate biopsy
- Prostate MRI (in some cases)
Treatment if necessary
If your cancer is growing more quickly than expected or changes grades, your doctor may recommend active treatment (radical prostatectomy, radiation therapy, and/or hormone therapy).
Around 25–30% of men under active surveillance end up having to undergo treatment because of signs of cancer growth. The cure rate remains the same as if you had not had active surveillance.
Emotions you may feel
It is normal to worry about your cancer growing and spreading faster than expected. Some men may find it too stressful to have their prostate cancer watched or monitored without active treatment. For these men, immediate therapy may be the preferred option. If you have concerns, talk to your doctor.
What you can do
Think about your values
Most men with low-risk prostate cancer have time to think about their choices. These tips may help you reach a decision.
Discuss these questions with your spouse or partner:
- Do I want to get rid of my cancer, even if I might have sexual or urinary problems?
- Which side effects would upset me most?
- Would I be okay with active surveillance, even if I am worried and have to see the doctor more often?
Review your health history
- Give your cancer care team your full personal and family medical histories.
- Ask how your age and general health could affect treatment
- Ask if you have any condition that might increase the risks of treatment, for example, conditions such as diabetes, heart problems, or bowel disease might increase your risk of sexual, urinary, or bowel problems.
Learn
Find out all of your treatment options
Ask your doctors about each choice, including benefits and side effects. Some doctors only suggest the option they know best. Typically:
- a radiation oncologist can discuss active surveillance and radiation treatment.
- a urologist can discuss active surveillance and surgery.
Talk about your choices with these physicians and your family doctor.
What is watchful waiting?
As mentioned at the beginning of this page, watchful waiting is different from active surveillance. Older men or men diagnosed with a slow-growing cancer who are suffering from other more life-threatening diseases will die before cancer poses a threat.
When all signs indicate the cancer is slow growing or that your life expectancy is less than 10 years, the selected course of action may be to wait for symptoms to appear before beginning treatment. This is called watchful waiting. It is important in certain cases to weigh the inconvenience of treatment with the risk posed by the cancer.
This surveillance mode allows initiation of a treatment only when the cancer causes symptoms, in order to treat them. In this case, the goal of any future treatment will not be to cure your cancer, but to control your symptoms. This is called palliative treatment.
If your doctor has suggested watchful waiting, your medical follow-ups will include a PSA test, a physical examination, including a digital rectal examination (DRE), a bone scan or other tests as needed and if your cancer progresses, your doctor will address it. This is a case by case approach.
We are here for you
You have questions or concerns? Don’t hesitate. Contact us at 1-855-899-2873 to discuss with one of our nurses specialized in uro-oncology. They are there to listen, support and answer your questions, and those of your family or your loved ones. It’s simple and free, like all of our other services.
Also take the time to visit each of our pages on this website, as well as our YouTube channel, in order to get familiar with the disease, our expert lectures, our section on available resources, the support that is offered to you, our events and ways to get involved to advance the cause.
Staying Informed
Pages that might interest you
Want to know more? Just click on one of the links below.
The latest PROCURE news that might interest you
Every week we publish a blog article. Here are some we have chosen for you.
- Did you say prostate cancer?
- I want to postpone my treatment… Is that wise?
- I have several treatment options… Which one to choose?
The medical content and editorial team at PROCURE
Our team is composed of urologists, and nurses certified in uro-oncology with a deep knowledge of prostate cancer and other diseases related to the genitourinary system. Meet our staff by clicking here.
Sources and references
- Prostate Cancer – Understand the disease and its treatments; Fred Saad, MD, FRCSC and Michael McCormack, MD, FRCSC, 4th et 5th editions
- Canadian Cancer Society
- Prostate Cancer Foundation-PCF.org
- National Cancer Institute-USA
- American Cancer Society
- Memorial Sloan Kettering Cancer Center
- Prostate Cancer UK
Last medical and editorial review: September 2023
Written by PROCURE. © All rights reserved
Active surveillance
- Treatment options
- Active surveillance
- Anatomy
- Structure
- Function
Active surveillance
Active surveillance
As surprising as it may seem, in some cases, if your cancer is confined within the prostate, your doctor may recommend waiting before you start treatment. He could opt for watchful waiting or active surveillance. There is a difference between the two approaches. Although we will address both approaches, the majority of the information on this page is about active surveillance, a treatment option for localized low-risk prostate cancer.
Active surveillance is a method of monitoring slow-growing prostate cancer rather than treating it immediately. The goal is to avoid unnecessary treatment or to delay treatment and potential side effects.
How does it work?
Often, prostate cancer progresses very slowly and may not cause symptoms, spread, or threaten your life for a long time. Active surveillance may be a treatment option if you have prostate cancer that is unlikely to progress significantly.
What does active surveillance involve?
While the term “active surveillance” may suggest inactivity, it is actually a dynamic program focused on closely monitoring cancer progression. Your healthcare team will carefully observe you and administer treatment if signs of tumor growth or an increased risk of cancer progression are detected.
Who is eligible for active surveillance?
Active surveillance may be offered if you have early-stage, low-grade cancer that is likely to grow slowly. This approach can help avoid the erectile dysfunction and incontinence risks associated with treatment (at least temporarily).
What is watchful waiting?
As mentioned earlier, watchful waiting is different from active surveillance. It is common for elderly men or those with slow-growing cancer and other significant health problems to die before the cancer becomes life-threatening.
When it is evident that your cancer will progress slowly and your life expectancy is less than 10 years, your doctor may prefer to wait until the disease manifests itself before starting treatment. This is called watchful waiting. In some cases, it is important to weigh the disadvantages of treatment against the risks posed by cancer.
Watchful waiting allows treatment to be initiated only when the cancer causes symptoms, to treat them. In this case, the goal of any future treatment will not be to cure your cancer but to manage your symptoms. This is referred to as palliative treatment.
If your doctor has recommended watchful waiting, your monitoring may include PSA testing, a physical examination, including a digital rectal exam (DRE), a bone scan, or other tests as needed, and if your cancer progresses, your doctor will address it. However, this approach varies case by case.
The decision to opt for active surveillance depends on various factors: your overall health, age, and family history. This option also depends on the aggressiveness of the cancer. Low-risk, well-differentiated cancers are generally less aggressive and slower to develop. Thus, active surveillance may be a treatment option if:
- Few samples are positive following your biopsy
- Your cancer is low-grade (Gleason score of 6), limited to your prostate
- Your PSA level is less than 10 ng/mL
- You have no symptoms
- You prefer not to undergo immediate treatment to avoid side effects and preserve your quality of life
Advantages and disadvantages
Advantages
- Avoids unnecessary treatments
- Avoids side effects
Disadvantages
- Frequent follow-up visits and tests
- Induces stress and anxiety in many patients
- Natural history of each patient’s cancer can differ
Risks and Complications
Although there are no tools that are 100% reliable for predicting disease progression, the risk of your cancer progressing to a more advanced stage or missing a treatment window is extremely rare due to your close monitoring. Your doctor will begin treatment once symptoms or signs of disease progression appear. The cure rate remains the same, and treatment after active surveillance is no more complicated or causes more side effects.
Regular tests
Regular tests will be done about every 3–6 months to monitor your prostate cancer. This can vary depending on your situation.
- Prostate-specific antigen (PSA) test
- Physical examination, including a digital rectal exam (DRE)
- Prostate biopsy
- Prostate MRI (in some cases)
Treatment if necessary
If your cancer is growing more quickly than expected or changes grades, your doctor may recommend active treatment (radical prostatectomy, radiation therapy, and/or hormone therapy).
Around 25–30% of men under active surveillance end up having to undergo treatment because of signs of cancer growth. The cure rate remains the same as if you had not had active surveillance.
Emotions you may feel
It is normal to worry about your cancer growing and spreading faster than expected. Some men may find it too stressful to have their prostate cancer watched or monitored without active treatment. For these men, immediate therapy may be the preferred option. If you have concerns, talk to your doctor.
What you can do
Think about your values
Most men with low-risk prostate cancer have time to think about their choices. These tips may help you reach a decision.
Discuss these questions with your spouse or partner:
- Do I want to get rid of my cancer, even if I might have sexual or urinary problems?
- Which side effects would upset me most?
- Would I be okay with active surveillance, even if I am worried and have to see the doctor more often?
Review your health history
- Give your cancer care team your full personal and family medical histories.
- Ask how your age and general health could affect treatment
- Ask if you have any condition that might increase the risks of treatment, for example, conditions such as diabetes, heart problems, or bowel disease might increase your risk of sexual, urinary, or bowel problems.
Learn
Find out all of your treatment options
Ask your doctors about each choice, including benefits and side effects. Some doctors only suggest the option they know best. Typically:
- a radiation oncologist can discuss active surveillance and radiation treatment.
- a urologist can discuss active surveillance and surgery.
Talk about your choices with these physicians and your family doctor.
Additional Information - Active surveillance
How I coped with prostate cancer
A man with prostate cancer shares the challenges of his cancer experience.
Urologist’s advice: Treatments and information on prostate cancer
Learn more about the role of the urologist and the importance for a patient to gather adequate information after receiving a prostate cancer diagnosis.
Prostate cancer: Tests, imaging and biomarkers
Discussion about the variety of approaches available to monitor this disease before, during, or after treatment.
Is prostate cancer hereditary?
Understanding the hereditary and genetic aspects of this disease can provide valuable information to both individuals affected and their families.
Symptoms, risk and screening
Are you over 50 or experiencing urinary problems? Discover why early screening for prostate diseases is important.
Diagnosis and treatment
Recently diagnosed with cancer? Educate yourself to fully understand your situation.
The role of hormone therapy
Has your doctor recommended hormone therapy? This video is for you!
States of prostate cancer following treatment
Do your recent tests show an increase in PSA levels? It could indicate a recurrence.
External radiation or Brachytherapy?
Explore the benefits and considerations of each treatment option for prostate cancer to determine which might be right for you.
Q-A – New therapies for advance prostate cancer
In this interview, we answer patients’ questions about new therapies for advanced prostate cancer.
Genetic predisposition to prostate cancer
Although rare, some hereditary genetic mutations can increase your risk of prostate cancer.
All about hormone therapy
Hormone therapy can reduce tumor size, control cancer, and prolong life. Is it the right treatment for your cancer?
Active surveillance in 5 points
As surprising as it may seem, your doctor may prefer to wait before starting treatment.
States of prostate cancer post-treatment
Gentlemen, you’re being treated for prostate cancer, and your latest blood tests show an increase in PSA levels?
Your role as a patient
Have you been diagnosed with prostate cancer? Your role as a patient is essential throughout your journey.
Me a guinea pig?
Did you know that participating in a clinical trial advances medical science and improves the lot of patients for future generations?
Sources and references
Last medical and editorial review: April 2024. See our web page validation committee and our collaborators by clicking here.
On this page:
Discover our animated video!
Symptoms, risk and screening
Are you over 50 years old, or have you been having urinary problems for some time now? This video is for you! Several diseases can affect your prostate, and it’s important to detect them early. Let’s take a closer look.
Anatomy
What is the prostate
The prostate is a gland:
- Located between the bladder and the penis, just in front of the rectum;
- Formed of 2 lobes which surround the urethra, a canal that runs through the center of the prostate, from the bladder to the penis, letting urine and sperm flow out of the body;
- The size of a walnut, which grows larger in size in your forties;
- That has a soft, spongy texture to the touch like a small, ripe plum.
The prostate is made of:
- Gland cells that secrete liquids for ejaculation;
- Muscle cells that participate in the evacuation of your sperm during ejaculation;
- Fiber cells that maintain the structure of the gland.
Around the prostate, we find:
- The seminal vesicles, glands that produce sperm and that are located on either side of the prostate;
- The vas deferens, the tube that carries sperm from the testicle to the seminal vesicles;
- The nerve bundles that control your bladder and erectile function and that are located on either side of your prostate.
Structure
Three main zones of the prostate
Peripheral zone
- The peripheral zone is the largest area of the prostate. It can easily be felt by the doctor during a digital rectal exam (DRE).
- Most prostate cancers start in the peripheral zone.
Transition zone
- This is the area located in the middle of the prostate, between the peripheral and central areas. It surrounds your urethra that runs through the prostate.
- With age, the transitional area increases in size until it becomes the largest portion of your prostate. This is called benign prostatic hyperplasia (BPH) or enlarged prostate.
Central zone
- It is the part of the prostate that is farthest from the rectum. This is why prostate tumors located in this area can not be felt by the doctor during a digital rectal examination.
- If the doctor is in doubt, the following information will help decide if additional investigation is necessary:
- Your PSA level
- Your age and family history
- Your ethnic origin
Fonction
In short
Your fertility and natural fertilization
- It produces … a prostatic fluid rich in enzymes, proteins and minerals that nourishes and protects your spermatozoa.
- It makes … a protein (APS) that is used to liquefy your sperm to facilitate the mobility of your spermatozoa.
- It allows … ejaculation by contracting.
- It promotes … fertility through its enzymes facilitating the penetration of sperm through the cervix.
- It is not related to the mechanism of erection. Therefore, the origin of erectile dysfunction lies elsewhere.
Additional details
Exocrine Function
The prostate is made up of thousands of tiny fluid-producing glands. Specifically, the prostate is an exocrine gland. Exocrine glands are so-called because they secrete through ducts to the outside of the body (or into a cavity that communicates with the outside). Sweat glands are another example of an exocrine gland.
The fluid that the prostate gland produces forms part of semen, the fluid that carries sperm during orgasm. This fluid, produced in the prostate, is stored with sperm in the seminal vesicles. When the male climaxes, muscular contractions cause the prostate to secrete this fluid into the urethra, where it is expelled from the body through the penis.
Urine Flow
The prostate wraps itself around the urethra as it passes from the bladder to the penis. Prostatic changes can affect urine flow. Increasing the size of the prostate or muscle tone may impede the flow of urine due to the close anatomical relationship between the urethra and the prostate.
Prostate Specific Antigen (PSA)
The prostate also produces a protein called prostate-specific antigen (PSA). PSA is released with the ejaculatory fluid and can also be traced in the bloodstream. The testing of PSA levels in the blood is used to detect prostate cancer. The level of PSA in the blood is usually measured in nanograms of PSA per milliliter of blood (ng/mL).
A raised PSA level
Usually, a PSA rate of less than 4 nanograms per milliliter of blood is normal, but age should also be taken into consideration as PSA levels gradually increase with age. A rise in PSA concentration may indicate the presence of:
- An enlarged prostate (benign prostatic hyperplasia)
- An inflammation or infection of the prostate (prostatitis)
- A prostate cancer
Your doctor will have you undergo other tests to determine the exact cause of the increase in your PSA.
We are here for you
You have questions or concerns? Don’t hesitate. Contact us at 1-855-899-2873 to discuss with one of our nurses specialized in uro-oncology. They are there to listen, support and answer your questions, and those of your family or your loved ones. It’s simple and free, like all of our other services.
Also take the time to visit each of our pages on this website, as well as our YouTube channel, in order to get familiar with the disease, our expert lectures, our section on available resources, the support that is offered to you, our events and ways to get involved to advance the cause..
Staying Informed
Pages that might interest you
Want to know more? Just click on one of the links below.
The latest PROCURE news that might interest you
Every week we publish a blog article. Here are some for you.
The medical content and editorial team at PROCURE
Our team is composed of urologists, and nurses certified in uro-oncology with a deep knowledge of prostate cancer and other diseases related to the genitourinary system. Meet our staff by clicking here.
Sources and references
- Prostate Cancer – Understand the disease and its treatments; Fred Saad, MD, FRCSC and Michael McCormack, MD, FRCSC, 4th et 5th editions
- Canadian Cancer Society
- Prostate Cancer Foundation-PCF.org
- National Cancer Institute-USA
- American Cancer Society
- Memorial Sloan Kettering Cancer Center
- Prostate Cancer UK
Last medical and editorial review: September 2023
Written by PROCURE. © All rights reserved